Polymorphisms in fatty acid metabolism-related genes are associated with colorectal cancer risk

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 466-472

  Hoeft, Birgit ^a   Linseisen, Jakob ^a,b   Beckmann, Lars ^a   Müller Decker, Karin ^a   Canzian, Federico ^a   Hüsing, Anika ^a   Kaaks, Rudolf ^a   Vogel, Ulla ^c,d   Jakobsen, Marianne U ^e   Overvad, Kim ^e   Hansen, Rikke D ^f   Knüppel, Sven ^g   Boeing, Heiner ^g   Trichopoulou, Antonia ^h,i   Koumantaki, Yvoni ^h   Trichopoulos, Dimitrios ^j   Berrino, Franco ^k   Palli, Domenico ^l   Panico, Salvatore ^m   Tumino, Rosario ⁿ   Buenode Mesquita, H B ^o   van Duijnhoven, Fränzel J B ^o   van Gils, Carla H ^p   Peeters, Petra H ^p,q   Dumeaux, Vanessa ^r   Lund, Eiliv ^r   Huerta Castaño, José M ^s,t   Muñoz, Xavier ^u   Rodriguez, Laudina ^v   Barricarte, Aurelio ^s,w   Manjer, Jonas ^x   Jirström, Karin ^y,z   van Guelpen, Bethany ^aa   Hallmans, Göran ^aa   Spencer, Elizabeth A ^ab   Crowe, Francesca L ^ab   Khaw, Kay Tee ^ac   Wareham, Nick ^ad   Morois, Sophie ^ae   Boutron Ruault, Marie Christine ^ae   Clavel Chapelon, Françxoise ^ae   Chajes, Veronique ^af   Jenab, Mazda ^af   Boffetta, Paolo ^af   Vineis, Paolo ^q,ag   Mouw, Traci ^q   Norat, Teresa ^q   Riboli, Elio ^q   Nieters, Alexandra ^a,ah   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ HELLENIC HEALTH FOUNDATION   (Greece)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^k NATIONAL CANCER INSTITUTE   (Italy)

^l CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^m UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁿ CIVILE M P AREZZO HOSPITAL   (Italy)

^o NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q IMPERIAL COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF TROMSØ   (Norway)

^s CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^t Regional Council of Health and Consumer Affairs   (Spain)

^u CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^v Health and Health Care Services Council   (Spain)

^w INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^x LUND UNIVERSITY HOSPITAL   (Sweden)

^y LUND UNIVERSITY   (Sweden)

^z LUND UNIVERSITY   (Sweden)

^aa UMEÅ UNIVERSITY   (Sweden)

^ab UNIVERSITY OF OXFORD   (United Kingdom)

^ac UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ad MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ae INSTITUT GUSTAVE ROUSSY   (France)

^af INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ag UNIVERSITY OF TURIN   (Italy)

^ah UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; PHOSPHOLIPASE A2 GROUP VI; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 2; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 3; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; FATTY ACID; PHOSPHOLIPASE A2 GROUP III; PLA2G3 PROTEIN, HUMAN; PLA2G6 PROTEIN, HUMAN; PROSTAGLANDIN EP2 RECEPTOR; TRPV3 PROTEIN, HUMAN; TUMOR PROTEIN; VANILLOID RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; ALLELE; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL TUMOR; EUROPE; GENETICS; GENOTYPE; METABOLISM; MULTICENTER STUDY; SMOKING;

ADENOCARCINOMA; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; EUROPE; FATTY ACIDS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; GROUP III PHOSPHOLIPASES A2; GROUP VI PHOSPHOLIPASES A2; HAPLOTYPES; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; MALE; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROSTAGLANDIN E; SMOKING; TRPV CATION CHANNELS;

EID: 77950886948     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp325     Document Type: Article

References (63)

1. Tenesa, A. et al. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet., 40, 631-637.
2. World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR). (2007) Second Expert Report: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington, DC, pp. 280-288.
3. Johnson, I.T. et al. (2007) Review article: nutrition, obesity and colorectal cancer. Aliment. Pharmacol. Ther., 26, 161-181.
4. Geelen, A. et al. (2007) Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am. J. Epidemiol., 166, 1116-1125.
5. Jones, R. et al. (2003) Arachidonic acid and colorectal carcinogenesis. Mol. Cell. Biochem., 253, 141-149.
6. Sinicrope, F.A. et al. (2004) Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev., 23, 63-75.
7. Wang, M.T. et al. (2007) Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev., 26, 525-534.
8. Chell, S. et al. (2006) Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochim. Biophys. Acta, 1766, 104-119.
9. Ota, S. et al. (2002) Review article: COX-2, prostanoids and colon cancer. Aliment. Pharmacol. Ther., 16 (suppl. 2), 102-106.
10. Ali, I.U. et al. (2005) Allellic variants in regulatory regions of cyclooxygenase2: association with advanced colorectal adenoma. Br.J.Cancer, 93, 953-959.
11. Tan, W. et al. (2007) Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis, 28, 1197-1201.
12. Gong, Z. et al. (2007) Common polymorphisms in 5-lipoxygenase and 12lipoxygenase genes and the risk of incident, sporadic colorectal adenoma. Cancer, 109, 849-857.
13. Goodman, J.E. et al. (2004) Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis, 25, 2467-2472.
14. Siezen, C.L. et al. (2006) Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta. Pharmacogenet. Genomics, 16, 43-50.
15. Koh, W.P. et al. (2006) Peroxisome proliferator-activated receptor (PPAR) gamma gene polymorphisms and colorectal cancer risk among Chinese in Singapore. Carcinogenesis, 27, 1797-1802.
16. Landi, S. et al. (2003) Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res., 63, 3560-3566.
17. Ulrich, C.M. et al. (2005) PTGS2 (COX-2) -765G . C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal antiinflammatory drugs. Cancer Epidemiol. Biomarkers Prev., 14, 616-619.
18. Cox, D.G. et al. (2004) Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br. J. Cancer, 91, 339-343.
19. Maltese, P. et al. (2009) VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int. J. Colorectal Dis., 24, 165-170.
20. Kim, J.G. et al. (2008) Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin. Cancer Res., 14, 62-66.
21. Riboli, E. et al. (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr., 5, 1113-1124.
22. de Bakker, P.I. et al. (2005) Efficiency and power in genetic association studies. Nat. Genet., 37, 1217-1223.
23. Barrett, J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
24. Gabriel, S.B. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
25. Wacholder, S. et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst., 96, 434-442.
26. Wakefield, J. (2007) A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am. J. Hum. Genet., 81, 208-227.
27. Wakefield, J. (2008) Reporting and interpretation in genomewide association studies. Int. J. Epidemiol., 37, 641-653.
28. Lake, S.L. et al. (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum. Hered., 55, 56-65.
29. Schaid, D.J. et al. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.
30. Mounier, C.M. et al. (2008) Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2III as a biomarker candidate. Br. J. Cancer, 98, 587-595.
31. Murakami, M. et al. (2005) Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2). J. Biol. Chem., 280, 24987-24998.
32. Aggarwal, A. et al. (2006) Topological and functional discovery in a gene coexpression meta-network of gastric cancer. Cancer Res., 66, 232-241.
33. Kury, S. et al. (2008) Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer, 8, 326.
34. Pereira, C. et al. (2009) Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? Eur. J. Gastroenterol. Hepatol., 21, 76-91.
35. Siezen, C.L. et al. (2005) Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption. Carcinogenesis, 26, 449-457.
36. Brosens, L.A. et al. (2005) Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G-< C COX-2 polymorphism. Clin. Cancer Res., 11, 4090-4096.
37. Koh, W.P. et al. (2004) Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study. Br. J. Cancer, 90, 1760-1764.
38. Greenhough, A. et al. (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30, 377-386.
39. Nandy, A. et al. (2003) Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene. J. Mol. Endocrinol., 31, 105-121.
40. Uppal, S. et al. (2008) Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat. Genet., 40, 789-793.
41. Tariq, M. et al. (2009) Mutation in the HPGD gene encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC). J. Med. Genet., 46, 14-20.
42. McCoy, J.M. et al. (2002) The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest., 110, 651-658.
43. Sonoshita, M. et al. (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat. Med., 7, 1048-1051.
44. Yang, L. et al. (2003) Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J. Clin. Invest., 111, 727-735.
45. Kamiyama, M. et al. (2006) EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene, 25, 7019-7028.
46. Seno, H. et al. (2002) Cyclooxygenase 2and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res., 62, 506-511.
47. Wong, N.A. et al. (2002) Beta-catenin-a linchpin in colorectal carcinogenesis? Am. J. Pathol., 160, 389-401.
48. Jinnai, N. et al. (2004) Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum. Mol. Genet., 13, 3203-3217.
49. Kim, S.H. et al. (2007) Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet. Genomics, 17, 295-304.
50. Hegener, H.H. et al. (2006) Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach. J. Thromb. Haemost., 4, 1718-1722.
51. Chow, S.C. et al. (1990) Inhibition of receptor-mediated calcium influx in T cells by unsaturated non-esterified fatty acids. Biochem. J., 267, 727-732.
52. Iacopetta, B. (2002) Are there two sides to colorectal cancer? Int. J. Cancer, 101, 403-408.
53. Huncharek, M. et al. (2009) Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26, 335 cases from 60 observational studies. Nutr. Cancer, 61, 47-69.
54. Wu, K. et al. (2002) Calcium intake and risk of colon cancer in women and men. J. Natl Cancer Inst., 94, 437-446.
55. Slattery, M.L. et al. (2006) PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulinrelated genes (United States). Cancer Causes Control, 17, 239-249.
56. Gervaz, P. et al. (2004) Two colons-two cancers: paradigm shift and clinical implications. J. Surg. Oncol., 88, 261-266.
57. A haplotype map of the human genome. Nature, 437, 1299-1320.
58. Carlson, C.S. et al. (2004) Selecting a maximally informative set of singlenucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet., 74, 106-120.
59. Hinds, D.A. et al. (2006) Common deletions and SNPs are in linkage disequilibrium in the human genome. Nat. Genet., 38, 82-85.
60. McCarroll, S.A. et al. (2006) Common deletion polymorphisms in the human genome. Nat. Genet., 38, 86-92.
61. Knowler, W.C. et al. (1988) Gm3;5, 13, 14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am. J. Hum. Genet., 43, 520-526.
62. Kittles, R.A. et al. (2002) CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification? Hum. Genet., 110, 553-560.
63. Wacholder, S. et al. (2002) Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol. Biomarkers Prev., 11, 513-520.